世界の良性前立腺肥大症検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Benign Prostatic Hyperplasia Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0742
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、良性前立腺肥大症検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（尿検査、前立腺特異抗原（PSA）血液検査、尿流動態検査、膀胱鏡検査）、用途別市場規模（病院、診断センター、クリニック、研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・良性前立腺肥大症検査の市場動向
・企業の競争状況、市場シェア
・良性前立腺肥大症検査の種類別市場規模（尿検査、前立腺特異抗原（PSA）血液検査、尿流動態検査、膀胱鏡検査）
・良性前立腺肥大症検査の用途別市場規模（病院、診断センター、クリニック、研究機関）
・良性前立腺肥大症検査の北米市場規模2016-2027（アメリカ、カナダ）
・良性前立腺肥大症検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・良性前立腺肥大症検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・良性前立腺肥大症検査の中南米市場規模2016-2027（メキシコ、ブラジル）
・良性前立腺肥大症検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AEternaZentaris、Astellas Pharma、Eli Lilly and Company、IntelGenx Technologies Corp、Nymox Pharmaceutical Corporation、Protox Therapeutics、Quest PharmaTech）
・結論

Benign prostatic hyperplasia (BPH) is a condition occurring in men when the prostate gland is enlarged. Benign prostatic hyperplasia is also termed as benign prostatic hypertrophy or benign prostatic obstruction. Prostate gland grows in primarily two phases, firstly during puberty when the size of the prostate doubles and the second growth phase starts at 25 years and continues throughout the lifetime. While the prostate gland enlarges in a man, it presses and pinches the urethra making the bladder wall thick. This pressure and squeeze on the urethra weaken the bladder and makes it lose the ability to empty the urine completely. Urinary retention and narrowing of the urethra can cause many problems which are associated with benign prostatic hyperplasia. Benign prostatic hyperplasia is one of the common prostate problems for men older than age 50.
Benign prostatic hyperplasia testing market is primarily driven by a few key factors such as the growing geriatric male population, patient awareness regarding rising healthcare concerns, increase in healthcare expenditure, increasing government initiatives and availability of minimally invasive surgery as a drug replacement, faster and easy performing diagnosis test results. The market is likely to grow owing to the novel diagnostic methods which are accurate than the conventional PSA blood test for benign prostatic hyperplasia which is effective in diagnosis and is expected to fuel the growth of benign prostatic hyperplasia testing market.

Market Analysis and Insights: Global Benign Prostatic Hyperplasia Testing Market
The global Benign Prostatic Hyperplasia Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Benign Prostatic Hyperplasia Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Benign Prostatic Hyperplasia Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Benign Prostatic Hyperplasia Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Benign Prostatic Hyperplasia Testing market.

Global Benign Prostatic Hyperplasia Testing Scope and Market Size
Benign Prostatic Hyperplasia Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Benign Prostatic Hyperplasia Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Urinalysis
Prostate-Specific Antigen (PSA) Blood Test
Urodynamic Test
Cystoscopy

Segment by Application
Hospitals
Diagnostic Centers
Clinics
Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AEternaZentaris
Astellas Pharma
Eli Lilly and Company
IntelGenx Technologies Corp
Nymox Pharmaceutical Corporation
Protox Therapeutics
Quest PharmaTech

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Urinalysis
1.2.3 Prostate-Specific Antigen (PSA) Blood Test
1.2.4 Urodynamic Test
1.2.5 Cystoscopy
1.3 Market by Application
1.3.1 Global Benign Prostatic Hyperplasia Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Clinics
1.3.5 Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Benign Prostatic Hyperplasia Testing Market Perspective (2016-2027)
2.2 Benign Prostatic Hyperplasia Testing Growth Trends by Regions
2.2.1 Benign Prostatic Hyperplasia Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Benign Prostatic Hyperplasia Testing Historic Market Share by Regions (2016-2021)
2.2.3 Benign Prostatic Hyperplasia Testing Forecasted Market Size by Regions (2022-2027)
2.3 Benign Prostatic Hyperplasia Testing Industry Dynamic
2.3.1 Benign Prostatic Hyperplasia Testing Market Trends
2.3.2 Benign Prostatic Hyperplasia Testing Market Drivers
2.3.3 Benign Prostatic Hyperplasia Testing Market Challenges
2.3.4 Benign Prostatic Hyperplasia Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Benign Prostatic Hyperplasia Testing Players by Revenue
3.1.1 Global Top Benign Prostatic Hyperplasia Testing Players by Revenue (2016-2021)
3.1.2 Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Players (2016-2021)
3.2 Global Benign Prostatic Hyperplasia Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Benign Prostatic Hyperplasia Testing Revenue
3.4 Global Benign Prostatic Hyperplasia Testing Market Concentration Ratio
3.4.1 Global Benign Prostatic Hyperplasia Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Benign Prostatic Hyperplasia Testing Revenue in 2020
3.5 Benign Prostatic Hyperplasia Testing Key Players Head office and Area Served
3.6 Key Players Benign Prostatic Hyperplasia Testing Product Solution and Service
3.7 Date of Enter into Benign Prostatic Hyperplasia Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Benign Prostatic Hyperplasia Testing Breakdown Data by Type
4.1 Global Benign Prostatic Hyperplasia Testing Historic Market Size by Type (2016-2021)
4.2 Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Type (2022-2027)

5 Benign Prostatic Hyperplasia Testing Breakdown Data by Application
5.1 Global Benign Prostatic Hyperplasia Testing Historic Market Size by Application (2016-2021)
5.2 Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Benign Prostatic Hyperplasia Testing Market Size (2016-2027)
6.2 North America Benign Prostatic Hyperplasia Testing Market Size by Type
6.2.1 North America Benign Prostatic Hyperplasia Testing Market Size by Type (2016-2021)
6.2.2 North America Benign Prostatic Hyperplasia Testing Market Size by Type (2022-2027)
6.2.3 North America Benign Prostatic Hyperplasia Testing Market Size by Type (2016-2027)
6.3 North America Benign Prostatic Hyperplasia Testing Market Size by Application
6.3.1 North America Benign Prostatic Hyperplasia Testing Market Size by Application (2016-2021)
6.3.2 North America Benign Prostatic Hyperplasia Testing Market Size by Application (2022-2027)
6.3.3 North America Benign Prostatic Hyperplasia Testing Market Size by Application (2016-2027)
6.4 North America Benign Prostatic Hyperplasia Testing Market Size by Country
6.4.1 North America Benign Prostatic Hyperplasia Testing Market Size by Country (2016-2021)
6.4.2 North America Benign Prostatic Hyperplasia Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Benign Prostatic Hyperplasia Testing Market Size (2016-2027)
7.2 Europe Benign Prostatic Hyperplasia Testing Market Size by Type
7.2.1 Europe Benign Prostatic Hyperplasia Testing Market Size by Type (2016-2021)
7.2.2 Europe Benign Prostatic Hyperplasia Testing Market Size by Type (2022-2027)
7.2.3 Europe Benign Prostatic Hyperplasia Testing Market Size by Type (2016-2027)
7.3 Europe Benign Prostatic Hyperplasia Testing Market Size by Application
7.3.1 Europe Benign Prostatic Hyperplasia Testing Market Size by Application (2016-2021)
7.3.2 Europe Benign Prostatic Hyperplasia Testing Market Size by Application (2022-2027)
7.3.3 Europe Benign Prostatic Hyperplasia Testing Market Size by Application (2016-2027)
7.4 Europe Benign Prostatic Hyperplasia Testing Market Size by Country
7.4.1 Europe Benign Prostatic Hyperplasia Testing Market Size by Country (2016-2021)
7.4.2 Europe Benign Prostatic Hyperplasia Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size (2016-2027)
8.2 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Type
8.2.1 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Application
8.3.1 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Region
8.4.1 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Benign Prostatic Hyperplasia Testing Market Size (2016-2027)
9.2 Latin America Benign Prostatic Hyperplasia Testing Market Size by Type
9.2.1 Latin America Benign Prostatic Hyperplasia Testing Market Size by Type (2016-2021)
9.2.2 Latin America Benign Prostatic Hyperplasia Testing Market Size by Type (2022-2027)
9.2.3 Latin America Benign Prostatic Hyperplasia Testing Market Size by Type (2016-2027)
9.3 Latin America Benign Prostatic Hyperplasia Testing Market Size by Application
9.3.1 Latin America Benign Prostatic Hyperplasia Testing Market Size by Application (2016-2021)
9.3.2 Latin America Benign Prostatic Hyperplasia Testing Market Size by Application (2022-2027)
9.3.3 Latin America Benign Prostatic Hyperplasia Testing Market Size by Application (2016-2027)
9.4 Latin America Benign Prostatic Hyperplasia Testing Market Size by Country
9.4.1 Latin America Benign Prostatic Hyperplasia Testing Market Size by Country (2016-2021)
9.4.2 Latin America Benign Prostatic Hyperplasia Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size (2016-2027)
10.2 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Type
10.2.1 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Application
10.3.1 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Country
10.4.1 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AEternaZentaris
11.1.1 AEternaZentaris Company Details
11.1.2 AEternaZentaris Business Overview
11.1.3 AEternaZentaris Benign Prostatic Hyperplasia Testing Introduction
11.1.4 AEternaZentaris Revenue in Benign Prostatic Hyperplasia Testing Business (2016-2021)
11.1.5 AEternaZentaris Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Benign Prostatic Hyperplasia Testing Introduction
11.2.4 Astellas Pharma Revenue in Benign Prostatic Hyperplasia Testing Business (2016-2021)
11.2.5 Astellas Pharma Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Benign Prostatic Hyperplasia Testing Introduction
11.3.4 Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Testing Business (2016-2021)
11.3.5 Eli Lilly and Company Recent Development
11.4 IntelGenx Technologies Corp
11.4.1 IntelGenx Technologies Corp Company Details
11.4.2 IntelGenx Technologies Corp Business Overview
11.4.3 IntelGenx Technologies Corp Benign Prostatic Hyperplasia Testing Introduction
11.4.4 IntelGenx Technologies Corp Revenue in Benign Prostatic Hyperplasia Testing Business (2016-2021)
11.4.5 IntelGenx Technologies Corp Recent Development
11.5 Nymox Pharmaceutical Corporation
11.5.1 Nymox Pharmaceutical Corporation Company Details
11.5.2 Nymox Pharmaceutical Corporation Business Overview
11.5.3 Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Testing Introduction
11.5.4 Nymox Pharmaceutical Corporation Revenue in Benign Prostatic Hyperplasia Testing Business (2016-2021)
11.5.5 Nymox Pharmaceutical Corporation Recent Development
11.6 Protox Therapeutics
11.6.1 Protox Therapeutics Company Details
11.6.2 Protox Therapeutics Business Overview
11.6.3 Protox Therapeutics Benign Prostatic Hyperplasia Testing Introduction
11.6.4 Protox Therapeutics Revenue in Benign Prostatic Hyperplasia Testing Business (2016-2021)
11.6.5 Protox Therapeutics Recent Development
11.7 Quest PharmaTech
11.7.1 Quest PharmaTech Company Details
11.7.2 Quest PharmaTech Business Overview
11.7.3 Quest PharmaTech Benign Prostatic Hyperplasia Testing Introduction
11.7.4 Quest PharmaTech Revenue in Benign Prostatic Hyperplasia Testing Business (2016-2021)
11.7.5 Quest PharmaTech Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Urinalysis
Table 3. Key Players of Prostate-Specific Antigen (PSA) Blood Test
Table 4. Key Players of Urodynamic Test
Table 5. Key Players of Cystoscopy
Table 6. Global Benign Prostatic Hyperplasia Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Benign Prostatic Hyperplasia Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Benign Prostatic Hyperplasia Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Benign Prostatic Hyperplasia Testing Market Share by Regions (2016-2021)
Table 10. Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Benign Prostatic Hyperplasia Testing Market Share by Regions (2022-2027)
Table 12. Benign Prostatic Hyperplasia Testing Market Trends
Table 13. Benign Prostatic Hyperplasia Testing Market Drivers
Table 14. Benign Prostatic Hyperplasia Testing Market Challenges
Table 15. Benign Prostatic Hyperplasia Testing Market Restraints
Table 16. Global Benign Prostatic Hyperplasia Testing Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Benign Prostatic Hyperplasia Testing Market Share by Players (2016-2021)
Table 18. Global Top Benign Prostatic Hyperplasia Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benign Prostatic Hyperplasia Testing as of 2020)
Table 19. Ranking of Global Top Benign Prostatic Hyperplasia Testing Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Benign Prostatic Hyperplasia Testing Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Benign Prostatic Hyperplasia Testing Product Solution and Service
Table 23. Date of Enter into Benign Prostatic Hyperplasia Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Benign Prostatic Hyperplasia Testing Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Type (2016-2021)
Table 27. Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Benign Prostatic Hyperplasia Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Application (2016-2021)
Table 31. Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Benign Prostatic Hyperplasia Testing Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Benign Prostatic Hyperplasia Testing Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Benign Prostatic Hyperplasia Testing Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Benign Prostatic Hyperplasia Testing Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Benign Prostatic Hyperplasia Testing Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Benign Prostatic Hyperplasia Testing Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Benign Prostatic Hyperplasia Testing Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Benign Prostatic Hyperplasia Testing Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Benign Prostatic Hyperplasia Testing Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Benign Prostatic Hyperplasia Testing Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Benign Prostatic Hyperplasia Testing Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Benign Prostatic Hyperplasia Testing Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Benign Prostatic Hyperplasia Testing Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Benign Prostatic Hyperplasia Testing Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Benign Prostatic Hyperplasia Testing Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Benign Prostatic Hyperplasia Testing Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Benign Prostatic Hyperplasia Testing Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Benign Prostatic Hyperplasia Testing Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Country (2022-2027) & (US$ Million)
Table 63. AEternaZentaris Company Details
Table 64. AEternaZentaris Business Overview
Table 65. AEternaZentaris Benign Prostatic Hyperplasia Testing Product
Table 66. AEternaZentaris Revenue in Benign Prostatic Hyperplasia Testing Business (2016-2021) & (US$ Million)
Table 67. AEternaZentaris Recent Development
Table 68. Astellas Pharma Company Details
Table 69. Astellas Pharma Business Overview
Table 70. Astellas Pharma Benign Prostatic Hyperplasia Testing Product
Table 71. Astellas Pharma Revenue in Benign Prostatic Hyperplasia Testing Business (2016-2021) & (US$ Million)
Table 72. Astellas Pharma Recent Development
Table 73. Eli Lilly and Company Company Details
Table 74. Eli Lilly and Company Business Overview
Table 75. Eli Lilly and Company Benign Prostatic Hyperplasia Testing Product
Table 76. Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Testing Business (2016-2021) & (US$ Million)
Table 77. Eli Lilly and Company Recent Development
Table 78. IntelGenx Technologies Corp Company Details
Table 79. IntelGenx Technologies Corp Business Overview
Table 80. IntelGenx Technologies Corp Benign Prostatic Hyperplasia Testing Product
Table 81. IntelGenx Technologies Corp Revenue in Benign Prostatic Hyperplasia Testing Business (2016-2021) & (US$ Million)
Table 82. IntelGenx Technologies Corp Recent Development
Table 83. Nymox Pharmaceutical Corporation Company Details
Table 84. Nymox Pharmaceutical Corporation Business Overview
Table 85. Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Testing Product
Table 86. Nymox Pharmaceutical Corporation Revenue in Benign Prostatic Hyperplasia Testing Business (2016-2021) & (US$ Million)
Table 87. Nymox Pharmaceutical Corporation Recent Development
Table 88. Protox Therapeutics Company Details
Table 89. Protox Therapeutics Business Overview
Table 90. Protox Therapeutics Benign Prostatic Hyperplasia Testing Product
Table 91. Protox Therapeutics Revenue in Benign Prostatic Hyperplasia Testing Business (2016-2021) & (US$ Million)
Table 92. Protox Therapeutics Recent Development
Table 93. Quest PharmaTech Company Details
Table 94. Quest PharmaTech Business Overview
Table 95. Quest PharmaTech Benign Prostatic Hyperplasia Testing Product
Table 96. Quest PharmaTech Revenue in Benign Prostatic Hyperplasia Testing Business (2016-2021) & (US$ Million)
Table 97. Quest PharmaTech Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Benign Prostatic Hyperplasia Testing Market Share by Type: 2020 VS 2027
Figure 2. Urinalysis Features
Figure 3. Prostate-Specific Antigen (PSA) Blood Test Features
Figure 4. Urodynamic Test Features
Figure 5. Cystoscopy Features
Figure 6. Global Benign Prostatic Hyperplasia Testing Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Clinics Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Benign Prostatic Hyperplasia Testing Report Years Considered
Figure 12. Global Benign Prostatic Hyperplasia Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Benign Prostatic Hyperplasia Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Benign Prostatic Hyperplasia Testing Market Share by Regions: 2020 VS 2027
Figure 15. Global Benign Prostatic Hyperplasia Testing Market Share by Regions (2022-2027)
Figure 16. Global Benign Prostatic Hyperplasia Testing Market Share by Players in 2020
Figure 17. Global Top Benign Prostatic Hyperplasia Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benign Prostatic Hyperplasia Testing as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Benign Prostatic Hyperplasia Testing Revenue in 2020
Figure 19. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Type (2016-2021)
Figure 20. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Type (2022-2027)
Figure 21. North America Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Benign Prostatic Hyperplasia Testing Market Share by Type (2016-2027)
Figure 23. North America Benign Prostatic Hyperplasia Testing Market Share by Application (2016-2027)
Figure 24. North America Benign Prostatic Hyperplasia Testing Market Share by Country (2016-2027)
Figure 25. United States Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Benign Prostatic Hyperplasia Testing Market Share by Type (2016-2027)
Figure 29. Europe Benign Prostatic Hyperplasia Testing Market Share by Application (2016-2027)
Figure 30. Europe Benign Prostatic Hyperplasia Testing Market Share by Country (2016-2027)
Figure 31. Germany Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Share by Region (2016-2027)
Figure 41. China Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Benign Prostatic Hyperplasia Testing Market Share by Type (2016-2027)
Figure 49. Latin America Benign Prostatic Hyperplasia Testing Market Share by Application (2016-2027)
Figure 50. Latin America Benign Prostatic Hyperplasia Testing Market Share by Country (2016-2027)
Figure 51. Mexico Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Share by Country (2016-2027)
Figure 57. Turkey Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. AEternaZentaris Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2016-2021)
Figure 61. Astellas Pharma Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2016-2021)
Figure 62. Eli Lilly and Company Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2016-2021)
Figure 63. IntelGenx Technologies Corp Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2016-2021)
Figure 64. Nymox Pharmaceutical Corporation Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2016-2021)
Figure 65. Protox Therapeutics Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2016-2021)
Figure 66. Quest PharmaTech Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の良性前立腺肥大症市場規模・現状・予測（2021年-2027年）

Global Benign Prostatic Hyperplasia Market Size, Status and Forecast 2021-2027
QYR2104Z0741 2021年4月 99Pages
QYResearch社発行の本調査資料では、良性前立腺肥大症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、透析、その他）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、...

世界の良性前立腺肥大症治療市場 2021：企業別、地域別、種類・用途別

Global Benign Prostatic Hyperplasia Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z02102 2021年4月 100Pages
当調査資料では、良性前立腺肥大症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。良性前立腺肥大症治療の種類別市場規模（アルファ遮断薬、5-アルファレダクターゼ阻害剤、ホスホジエステラーゼ-5阻害剤、その他）、用途別市場規模（単剤療法、併用薬物療法）...

世界のゾリンジャー-エリソン症候群検査市場規模・現状・予測（2021年-2027年）

Global Zollinger - Ellison Syndrome Testing Market Size, Status and Forecast 2021-2027
QYR2104Z6110 2021年4月 92Pages
QYResearch社発行の本調査資料では、ゾリンジャー-エリソン症候群検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（合成豚セクレチン、合成人間セクレチン）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の呼吸器適合性検査市場規模・現状・予測（2021年-2027年）

Global Respirator Suitability Testing Market Size, Status and Forecast 2021-2027
QYR2104Z5000 2021年4月 92Pages
QYResearch社発行の本調査資料では、呼吸器適合性検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（質的検査、量的検査）、用途別市場規模（警察・消防、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓...

世界のレトロウイルス検査市場規模・現状・予測（2021年-2027年）

Global Retrovirus Testing Market Size, Status and Forecast 2021-2027
QYR2104Z5028 2021年4月 94Pages
QYResearch社発行の本調査資料では、レトロウイルス検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血液、血清、体液、細胞）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、...

世界の種子検査市場規模・現状・予測（2021年-2027年）

Global Seed Testing Market Size, Status and Forecast 2021-2027
QYR2104Z5166 2021年4月 95Pages
QYResearch社発行の本調査資料では、種子検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（雑草検査、純度検査、生存率検査、発芽検査）、用途別市場規模（科学研究、政府、農業、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界のHPV検査市場規模・現状・予測（2021年-2027年）

Global HPV Testing Market Size, Status and Forecast 2021-2027
QYR2104Z2934 2021年4月 99Pages
QYResearch社発行の本調査資料では、HPV検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HPV検査、フォローアップHPV検査、共同検査）、用途別市場規模（子宮頸がん検診、膣がん検診、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界の血液検査市場規模・現状・予測（2021年-2027年）

Global Blood Testing Market Size, Status and Forecast 2021-2027
QYR2104Z0910 2021年4月 92Pages
QYResearch社発行の本調査資料では、血液検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ブドウ糖、脂質、BUN、A1C、CRP、ビタミンD、ALT、AST、甲状腺刺激ホルモン）、用途別市場規模（病院、クリニック・診断センター、その他...

世界の豚診断検査市場規模・現状・予測（2021年-2027年）

Global Swine Diagnostic Testing Market Size, Status and Forecast 2021-2027
QYR2104Z5521 2021年4月 94Pages
QYResearch社発行の本調査資料では、豚診断検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（イムノアッセイ（ELISA）キット、PCRキット、その他）、用途別市場規模（獣医病院、獣医クリニック）、主要地域別市場規模（北米、アメリカ、ヨ...

世界の梅毒検査市場規模・現状・予測（2021年-2027年）

Global Syphilis Testing Market Size, Status and Forecast 2021-2027
QYR2104Z5535 2021年4月 90Pages
QYResearch社発行の本調査資料では、梅毒検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（一次梅毒、二次梅毒）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南...

世界の良性前立腺肥大症市場規模・現状・予測（2021年-2027年） Benign prostatic hyperplasia (BPH) also known as benign prostatic hypertrophy is characterized by the unusual propagation of the prostatic cells, which causes difficulties like urinary retention and infections of the urinary tract. It is most common among the aging men population, primarily driving …
世界の良性前立腺肥大症治療市場 2021：企業別、地域別、種類・用途別 The Benign Prostatic Hyperplasia Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
世界の前立腺特異抗原（PSA）検査市場 2021：企業別、地域別、種類・用途別 The Prostate-Specific Antigen (PSA) Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
世界の血液ウイルス検査市場規模・現状・予測（2021年-2027年） Viral testing is carried out to detect infections caused by viruses by destroying cells of immune system. Viruses breed only in living cells and cause diseases by destructing or injuring the cells they infect, damaging the body's whole immune system, altering the genetic material (DNA) of the cells …
世界の抗原皮膚検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Antigen Skin Test Market The global Antigen Skin Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a…